Shield Therapeutics PLC (STXS)

London
9.50
0.00(0.00%)
  • Volume:
    21,878
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    9.50 - 9.50

STXS Overview

Prev. Close
9.5
Day's Range
9.5-9.5
Revenue
2.8M
Open
9.5
52 wk Range
5.52-52
EPS
-0.108
Volume
21,878
Market Cap
24.45M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,202,690
P/E Ratio
-1.04
Beta
1.32
1-Year Change
-75.95%
Shares Outstanding
257,387,708
Next Earnings Date
27 Jun 2023
What is your sentiment on Shield Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Shield Therapeutics PLC Company Profile

Shield Therapeutics PLC Company Profile

Employees
15

Shield Therapeutics plc is a United Kingdom-based commercial-stage specialty pharmaceutical company. The Company specializes in the development and commercialization of late-stage pharmaceuticals which address areas of unmet medical need. The Company's lead product, Feraccru/Accrufer (ferric maltol), is a stable, non-salt-based oral therapy for adults with iron deficiency with or without anemia. Ferric maltol is approved in the United States, European Union, United Kingdom and Switzerland for the treatment of iron deficiency with or without anemia in adults. Its pipeline product candidate, PT20, is an iron-based phosphate binder that has the potential to treat patients with hyperphosphatemia related to dialysis or non-dialysis dependent chronic kidney disease (CKD). PT20 has completed its Phase II pivotal study. Its subsidiaries include Shield Therapeutics (DE) GmbH, Shield TX (Switzerland) AG, Shield TX (UK) Limited, Phosphate Therapeutics Limited and Shield Therapeutics Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellStrong Sell
Technical IndicatorsSellSellSellStrong SellStrong Sell
SummaryNeutralNeutralSellStrong SellStrong Sell
  • Today 12p up 31%
    0
    • Why has this excellent share dropped so far off a cliff, surely 40p is its net asset value and then with markets opening in the US, a realistic price of 65p.
      0
      • 18p
        0
        • 21p well that's a shocker... And from being 15%up its now shocking... Has to be a BUY at 21p
          1
          • why is the sp dropping when the forecast for 2022 is in excess of £2.65p per share... what's happening ?? anyone bhave substantive knowledge
            0
            • 41p why the drop BUYING Opportunity?? Advice
              0
              • Every dip is oppty to buy
                1
            • Anonanon should they get anywhere near the bottom of your estimate, I'll be both happy and a rich guy... 160p would be a new house abroad..... I see 80p medium term and 140p by end of 2022..
              0
              • Im not taking profit until in the 100s
                0
              • Anon anon me neither and today is a buying opportunity
                0
            • Bear case: 60 to 80Base: 100 to 120Bull case: 160
              0
              • Excellent gains over the past 2 days... (countered on my portfolio by IAG and TUI) it would be nice if it gets to 65 and then onto 100p.... It would make a great start to the new year
                0
                • hopefully yes
                  0
              • Long term tgt 160 (4x from today's price)
                0
                • Ananoon. What makes you say that... Cause they are finally rising?
                  0
                • 12x projected earning in 2023
                  0